Formulation And Evaluation of Eczema Cream

Atopic dermatitis is often referred to as eczema, a chronic inflammatory skin disease. The formulation and evaluation of eczema creams is aimed at developing topical products that can reduce eczema symptoms such as swelling, inflammation, pain and redness of the skin layer. This study focuses on the preparation of emollient-based creams with active ingredients known for their anti-inflammatory, moisturizing and skin-saving properties. Creams were evaluated using the cream's physical properties such as viscosity, texture and pH values, as well as microbiological stability and durability in vitro and in vivo. Certain types of stimulation testing and clinical research were also conducted to ensure the safety and efficacy of the product. The results of this study show that the prescribed cream offers important relief offering potential alternatives to victims looking for appropriate topical effects with minimal negative outcomes. AD is often referred to as “itch that rashes” because the itching starts and then the skin rash follows as a result of scratching the rash which develops as a effect of a skin pigmentation wound, and occurs between fat deposition and pigmentation in the dark areas of eczema. The disease is attributed to a constructed interaction between genetic predisposition and natural factors that drive infants, childhood and adulthood in three stages.